$154.53
0.82% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Natera, Inc. Stock price

$154.53
+12.30 8.65% 1M
-13.35 7.95% 6M
-3.77 2.38% YTD
+48.22 45.36% 1Y
+114.57 286.71% 3Y
+108.00 232.11% 5Y
+131.79 579.55% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.26 0.82%
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Key metrics

Market capitalization $21.10b
Enterprise Value $20.30b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 238.35
EV/Sales (TTM) EV/Sales 11.09
P/S ratio (TTM) P/S ratio 11.52
P/B ratio (TTM) P/B ratio 16.94
Revenue growth (TTM) Revenue growth 51.50%
Revenue (TTM) Revenue $1.83b
EBIT (operating result TTM) EBIT $-227.16m
Free Cash Flow (TTM) Free Cash Flow $85.19m
Cash position $991.60m
EPS (TTM) EPS $-1.47
P/E forward negative
P/S forward 10.59
EV/Sales forward 10.19
Short interest 4.52%
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

22x Buy
96%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

Buy
96%
Sell
4%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,831 1,831
52% 52%
100%
- Direct Costs 700 700
16% 16%
38%
1,131 1,131
86% 86%
62%
- Selling and Administrative Expenses 881 881
41% 41%
48%
- Research and Development Expense 445 445
36% 36%
24%
-194 -194
43% 43%
-11%
- Depreciation and Amortization 33 33
18% 18%
2%
EBIT (Operating Income) EBIT -227 -227
41% 41%
-12%
Net Profit -190 -190
48% 48%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Positive
Seeking Alpha
5 days ago
Natera delivered stellar Q1 results, with revenue and EPS beating expectations, and strong volume growth, especially for its flagship Signatera product. Management sees significant upside for Signatera, projecting it could become a $5 billion annual product as both volumes and ASPs rise. Natera consistently outperforms its own conservative guidance, suggesting future earnings beats are likely, ...
Neutral
Seeking Alpha
12 days ago
Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript
Neutral
Business Wire
12 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the first quarter ended March 31, 2025. Recent Strategic and Financial Highlights Generated total revenues of $501.8 million in the first quarter of 2025, compared to $367.7 million in the first quarter of 2024, an increase of 36.5%. Prod...
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,434
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today